[HTML][HTML] The rising burden of cancer in the developing world
P Kanavos - Annals of oncology, 2006 - Elsevier
Cancer remains one of the leading causes of morbidity and mortality worldwide. It is
predicted that by 2020, the number of new cases of cancer in the world will increase to more …
predicted that by 2020, the number of new cases of cancer in the world will increase to more …
Clinical implications of HIV and hepatitis B co-infection in Asia and Africa
CJ Hoffmann, CL Thio - The Lancet infectious diseases, 2007 - thelancet.com
Hepatitis B virus (HBV) is the leading cause of chronic liver disease and liver-related death
worldwide, with the majority of these cases occurring in areas of Africa and Asia where HBV …
worldwide, with the majority of these cases occurring in areas of Africa and Asia where HBV …
[HTML][HTML] Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents
This report updates and combines earlier versions of guidelines for the prevention and
treatment of opportunistic infections (OIs) in HIV-infected adults (ie, persons aged> 18 years) …
treatment of opportunistic infections (OIs) in HIV-infected adults (ie, persons aged> 18 years) …
AIDS-related cancer and severity of immunosuppression in persons with AIDS
RJ Biggar, AK Chaturvedi, JJ Goedert… - Journal of the National …, 2007 - academic.oup.com
Abstract Background The incidence of Kaposi sarcoma, non-Hodgkin lymphoma, and
cervical cancer has been declining among persons with AIDS. We investigated the …
cervical cancer has been declining among persons with AIDS. We investigated the …
[HTML][HTML] Global disparities in access to cancer care
Global disparities in access to cancer care | Communications Medicine Skip to main content
Thank you for visiting nature.com. You are using a browser version with limited support for …
Thank you for visiting nature.com. You are using a browser version with limited support for …
Kaposi sarcoma: review and medical management update
M Fatahzadeh - Oral surgery, oral medicine, oral pathology and oral …, 2012 - Elsevier
Despite recent advances in our understanding of pathogenic mechanisms involved, the true
nature of Kaposi sarcoma remains an enigma. Four clinical variants have been described for …
nature of Kaposi sarcoma remains an enigma. Four clinical variants have been described for …
Lymphomas in sub‐Saharan Africa–what can we learn and how can we help in improving diagnosis, managing patients and fostering translational research?
KN Naresh, M Raphael, L Ayers… - British journal of …, 2011 - Wiley Online Library
Approximately 30 000 cases of non‐Hodgkin lymphoma (NHL) occur in the equatorial belt of
Africa each year. Apart from the fact that Burkitt lymphoma (BL) is very common among …
Africa each year. Apart from the fact that Burkitt lymphoma (BL) is very common among …
[HTML][HTML] Reactivation of Kaposi's sarcoma-associated herpesvirus from latency requires MEK/ERK, JNK and p38 multiple mitogen-activated protein kinase pathways
J Xie, AO Ajibade, F Ye, K Kuhne, SJ Gao - Virology, 2008 - Elsevier
Lytic replication of Kaposi's sarcoma-associated herpesvirus (KSHV) promotes the
progression of Kaposi's sarcoma (KS), a dominant malignancy in patients with AIDS. While …
progression of Kaposi's sarcoma (KS), a dominant malignancy in patients with AIDS. While …
[HTML][HTML] The challenge of AIDS-related malignancies in sub-Saharan Africa
Background With the lengthening of life expectancy among HIV-positive subjects related to
the use of highly active antiretroviral treatments, an increased risk of cancer has been …
the use of highly active antiretroviral treatments, an increased risk of cancer has been …
[HTML][HTML] HHV-8 seroprevalence: a global view
Background Human herpes virus 8 (HHV-8) is the underlying infectious cause of Kaposi
sarcoma (KS) and other proliferative diseases; that is, primary effusion lymphoma and …
sarcoma (KS) and other proliferative diseases; that is, primary effusion lymphoma and …